Announce Date | 05/08/2025 |
EPS Normalized Actual | $0.12 (Beat by $0.02) |
EPS GAAP Actual | $0.12 (Beat by $0.02) |
Revenue Actual | $0.177176B |
Revenue Surprise | Beat by $177.176M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.9677 | 3.2 | 0.93282 | 1.00258 | 1 |
Dec 2027 | 1.4517 | 2.14 | 1.35545 | 1.59569 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -1.25 | -1.25 | 0.177176B | 100% | 177.18M |
FQ4 2024 (Dec 2024) | 0 | 0 | 0.193517B | 100% | 193.52M |
FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 0.259784B | 100% | 259.78M |
FQ2 2024 (Jun 2024) | -0.11 | -0.11 | 0.203663B | 100% | 203.66M |
FQ4 2012 (Dec 2012) | 0.71 | 0.71 | 0.291472B | 100% | 291.47M |
FQ1 2013 (Mar 2013) | 0.58 | 0.58 | 0.272834B | 100% | 272.83M |
FQ2 2013 (Jun 2013) | 1.1 | 1.1 | 0.282399B | 100% | 282.4M |
FQ3 2013 (Sep 2013) | 0.51 | 0.51 | 0.313116B | 100% | 313.12M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 0.2726 | -- | 0.2726 | 0.2726 | 1 |
FQ3 2028 (Sep 2028) | 0.2762 | -- | 0.2762 | 0.2762 | 1 |
FQ2 2028 (Jun 2028) | 0.2665 | -- | 0.2665 | 0.2665 | 1 |
FQ1 2028 (Mar 2028) | 0.1524 | -- | 0.1524 | 0.1524 | 1 |
FQ4 2027 (Oct 2027) | 0.3696 | -- | 0.3696 | 0.3696 | 1 |
FQ3 2027 (Jul 2027) | 0.3625 | -- | 0.3625 | 0.3625 | 1 |
FQ2 2027 (Jun 2027) | 0.3621 | -- | 0.34692 | 0.37728 | 0 |
FQ1 2027 (Mar 2027) | 0.3545 | -- | 0.33963 | 0.36937 | 0 |
FQ4 2026 (Oct 2026) | 0.39625 | -- | 0.34849 | 0.44787 | 0 |
FQ3 2026 (Jul 2026) | 0.37735 | -- | 0.33187 | 0.42651 | 0 |
FQ2 2026 (Jun 2026) | 0.3514 | -- | 0.34958 | 0.35322 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 0.26B | -- | 0.26B | 0.26B | 1 |
FQ3 2028 (Sep 2028) | 0.25B | -- | 0.25B | 0.25B | 1 |
FQ2 2028 (Jun 2028) | 0.25B | -- | 0.25B | 0.25B | 1 |
FQ1 2028 (Mar 2028) | 0.24B | -- | 0.24B | 0.24B | 1 |
FQ4 2027 (Oct 2027) | 0.27B | -- | 0.27B | 0.27B | 1 |
FQ3 2027 (Jul 2027) | 0.26B | -- | 0.26B | 0.26B | 1 |
FQ2 2027 (Jun 2027) | 0.26B | -- | 0.25B | 0.27B | 1 |
FQ1 2027 (Mar 2027) | 0.25B | -- | 0.25B | 0.26B | 1 |
FQ4 2026 (Oct 2026) | 0.17B | -- | 0.15B | 0.18B | 1 |
FQ3 2026 (Jul 2026) | 0.17B | -- | 0.15B | 0.18B | 1 |
FQ2 2026 (Jun 2026) | 0.17B | -- | 0.17B | 0.17B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -1.25 | -1.25 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 100% | |
FQ2 2024 (Jun 2024) | -0.11 | -0.11 | 100% | |
FQ4 2012 (Dec 2012) | 0.71 | 0.71 | 100% | |
FQ1 2013 (Mar 2013) | 0.58 | 0.58 | 100% | |
FQ2 2013 (Jun 2013) | 1.1 | 1.1 | 100% | |
FQ3 2013 (Sep 2013) | 0.51 | 0.51 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.18B | $177.18M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.19B | $193.52M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.26B | $259.78M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.2B | $203.66M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.29B | $291.47M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0.27B | $272.83M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.28B | $282.4M | 100% |
FQ3 2013 (Sep 2013) | $0B | $0.31B | $313.12M | 100% |